These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22422322)

  • 1. A non-invasive, low-cost study design to determine the release profile of colon drug delivery systems: a feasibility study.
    Maurer MJ; Schellekens RC; Wutzke KD; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG; Stellaard F
    Pharm Res; 2012 Aug; 29(8):2070-8. PubMed ID: 22422322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
    Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
    J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotope-labelled urea to test colon drug delivery devices in vivo: principles, calculations and interpretations.
    Maurer MJ; Schellekens RC; Wutzke KD; Stellaard F
    Isotopes Environ Health Stud; 2013; 49(4):473-91. PubMed ID: 24313370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof-of-concept study on the suitability of 13C-urea as a marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms.
    Schellekens RC; Olsder GG; Langenberg SM; Boer T; Woerdenbag HJ; Frijlink HW; Kosterink JG; Stellaard F
    Br J Pharmacol; 2009 Sep; 158(2):532-40. PubMed ID: 19732063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ileocolonic drug delivery by the colopulse-system: a bioavailability study in healthy volunteers.
    Schellekens RC; Stellaard F; Olsder GG; Woerdenbag HJ; Frijlink HW; Kosterink JG
    J Control Release; 2010 Sep; 146(3):334-40. PubMed ID: 20621586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets.
    Maurer JM; Schellekens RC; van Rieke HM; Wanke C; Iordanov V; Stellaard F; Wutzke KD; Dijkstra G; van der Zee M; Woerdenbag HJ; Frijlink HW; Kosterink JG
    PLoS One; 2015; 10(7):e0129076. PubMed ID: 26177019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
    Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
    Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of lactose-[13C]ureide and lactose-[15N,15N]ureide in normal adults consuming a diet marginally adequate in protein.
    Jackson AA; Bundy R; Hounslow A; Murphy JL; Wootton SA
    Clin Sci (Lond); 1999 Nov; 97(5):547-55. PubMed ID: 10545305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-abundance plasma and urinary [(15)N]urea enrichments analyzed by gas chromatography/combustion/isotope ratio mass spectrometry.
    Metges CC; Daenzer M; Petzke KJ; Elsner A
    J Mass Spectrom; 2002 May; 37(5):489-94. PubMed ID: 12112754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of oro-coecal transit time: a comparison of the lactose-[13C, 15N]ureide 13CO2- and the lactulose H2-breath test in humans.
    Wutzke KD; Heine WE; Plath C; Leitzmann P; Radke M; Mohr C; Richter I; Gülzow HU; Hobusch D
    Eur J Clin Nutr; 1997 Jan; 51(1):11-9. PubMed ID: 9023461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The (13)C-urea breath test for non-invasive diagnosis of Helicobacter pylori infection: which procedure and which measuring equipment?
    Parente F; Bianchi Porro G
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):803-6. PubMed ID: 11474309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
    Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
    J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
    Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
    World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.
    Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
    J Control Release; 2008 Dec; 132(2):91-8. PubMed ID: 18775755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the biomarker 15N-lactose ureide allow to estimate the site of fermentation of resistant starch?
    Cloetens L; De Preter V; De Loor H; Rutgeerts P; Verbeke K
    Eur J Nutr; 2008 Jun; 47(4):217-23. PubMed ID: 18560788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of aminophylline delivered to the small intestine and colon using remote controlled capsules.
    Liu HY; Pi XT; Zheng XL; Hou WS; Cui JG
    Chin Med J (Engl); 2010 Feb; 123(3):320-5. PubMed ID: 20193253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15N-urea metabolism in the functioning human colon: luminal hydrolysis and mucosal permeability.
    Moran BJ; Jackson AA
    Gut; 1990 Apr; 31(4):454-7. PubMed ID: 2338273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approach to 13C-urea breath test: capsule-based modification with low-dose of 13C-urea in the diagnosis of Helicobacter pylori infection.
    Bielański W; Konturek SJ
    J Physiol Pharmacol; 1996 Sep; 47(3):545-53. PubMed ID: 8877910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules.
    Tuleu C; Basit AW; Waddington WA; Ell PJ; Newton JM
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1771-9. PubMed ID: 12269970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of guargum-based colon-targeted oral drug delivery systems of celecoxib in human volunteers.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):273-80. PubMed ID: 12587957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.